Insights

Clinical leadership MRIdian MRI-guided adaptive radiotherapy system with real-time imaging and on-table re-optimization presents a compelling platform for hospitals and cancer centers seeking precise, personalized radiation therapy.

Expansion potential Global adoption with over 12,500 patients treated across multiple sites indicates strong demand; opportunities exist for expanding installation, service, and training in new geographies and health systems.

Financial resilience Significant funding history including DIP financing and a total funding stack supports sales pursuits for larger procurement agreements, service contracts, and upgrade cycles.

Strategic partnerships Past collaborations with VieCure and other tech partners suggest open channels for AI, software portfolio expansion, and analytics-enabled treatment planning to enhance MRIdian capabilities.

Market positioning Distinct competitive advantage as the only MR solution with fully integrated adaptive treatment and automated beam gating offers a differentiator for sales conversations aimed at oncology centers prioritizing precision and workflow efficiency.

Similar companies to ViewRay, Inc.

ViewRay, Inc. Tech Stack

ViewRay, Inc. uses 8 technology products and services including MATLAB, SOLIDWORKS, Amazon Web Services, and more. Explore ViewRay, Inc.'s tech stack below.

ViewRay, Inc.'s Email Address Formats

ViewRay, Inc. uses at least 4 email formats:
ViewRay, Inc. Email FormatsExamplePercentage
FLast@viewray.comJDoe@viewray.com
90%
FirstLast@viewray.comJohnDoe@viewray.com
5%
First.Last@viewray.comJohn.Doe@viewray.com
4%
Last@viewray.comDoe@viewray.com
1%

Frequently Asked Questions

What is ViewRay, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact ViewRay, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is ViewRay, Inc.'s stock symbol?

Minus sign iconPlus sign icon
ViewRay, Inc. is a publicly traded company; the company's stock symbol is VRAYQ.

What is ViewRay, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
ViewRay, Inc.'s official website is viewray.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does ViewRay, Inc. generate?

Minus sign iconPlus sign icon
As of October 2026, ViewRay, Inc.'s annual revenue is estimated to be $10M - $25M.

What is ViewRay, Inc.'s NAICS code?

Minus sign iconPlus sign icon
ViewRay, Inc.'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does ViewRay, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2026, ViewRay, Inc. has approximately 61 employees across 3 continents, including North America, Europe and Asia. Key team members include Chief Scientific Officer: M. L., Head Of Investor Relations: M. H. and Owner: B. G. Explore ViewRay, Inc.'s employee directory with LeadIQ.

What industry does ViewRay, Inc. belong to?

Minus sign iconPlus sign icon
ViewRay, Inc. operates in the Medical Equipment Manufacturing industry.

What technology does ViewRay, Inc. use?

Minus sign iconPlus sign icon
ViewRay, Inc.'s tech stack includes MATLAB, SOLIDWORKS, Amazon Web Services, WordPress, Salesforce, Pardot, New Relic and Adobe Creative Suite.

What is ViewRay, Inc.'s email format?

Minus sign iconPlus sign icon
ViewRay, Inc.'s email format typically follows the pattern of FLast@viewray.com. Find more ViewRay, Inc. email formats with LeadIQ.

How much funding has ViewRay, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2026, ViewRay, Inc. has raised $878M in funding. The last funding round occurred on Dec 14, 2022 for $125M.

When was ViewRay, Inc. founded?

Minus sign iconPlus sign icon
ViewRay, Inc. was founded in 2004.
ViewRay, Inc. logo

ViewRay, Inc.

Medical Equipment ManufacturingOhio, United States51-200 Employees

ViewRay, Inc. is a medical equipment manufacturer based in Oakwood, Ohio. It develops the MRIdian MRI-guided adaptive radiotherapy system, which uses real-time imaging to distinguish the tumor from surrounding tissue during treatment. The system enables adaptive treatment through on-table re-optimization of the daily plan and automated beam gating to pause irradiation when the tumor moves.

Its customers include oncologists and cancer treatment centers seeking precise, personalized radiotherapy, and the company operates as a mid-sized player in medical devices. Since clinical deployment, MRIdian has treated more than 12,500 patients worldwide.

Section iconCompany Overview

Phone number
Stock Symbol
VRAYQ
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2004
Employees
51-200

Section iconFunding & Financials

  • $878M

    ViewRay, Inc. has raised a total of $878M of funding over 21 rounds. Their latest funding round was raised on Dec 14, 2022 in the amount of $125M as a Post IPO Debt.

  • $10M - $25M

    ViewRay, Inc.'s revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.